https://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/usmca-review-outcome-critical-for-north-american-beauty-industry-HTQIYHPDJBCZXFYKOPTUFD7R2I/2026-04-11T17:23:03.214Zalways0.5https://insights.citeline.com/resizer/0KRuJFPrWaWYEMb5CY_v6u6e2Ko=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MFOJRZVLAVEAREWGBJHFYBU6KU.jpghttps://insights.citeline.com/pink-sheet/policy-regulation/us-pharma-tariffs-exemptions-need-more-clarity-impact-varied-EJDAKYPZYNHA7FPUAYAYF3COJU/2026-04-11T05:55:12.498Zalways0.5https://insights.citeline.com/resizer/PvehnlJJAt1Q1w45VwWF_DTVdWw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ND5GEZFMFBHPPOYWL7A2UDQ7DA.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-replimune-cutting-jobs-as-fda-rejects-rp1-a-second-time-R7NN6KDVMVB65EL2YQQVSNVLJA/2026-04-11T03:16:05.379Zalways0.5https://insights.citeline.com/resizer/lX8-Vs0-l2lH5ZQHnromxpP0muA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7NTRUR6TDRO5XBZ2AHBDBYLEDM.jpghttps://insights.citeline.com/pink-sheet/podcasts/pink-sheet-podcast-leucovorins-resurrection-phrmas-leadership-change-CL23NOIHVRB73FXBAJANAPYIDY/2026-04-11T01:17:45.607Zalways0.5https://insights.citeline.com/resizer/Gg_gWrVctvsFBg1CcB-LKDTCOc4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JVY5PWDGIFNT3GV6SLTK2YSK5I.pnghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/real-world-evidence/canadas-hta-agency-launches-new-funding-to-strengthen-rare-disease-registries-and-rwd-ZAUDC5AUJFGDTMTWES6ZYCJWPQ/2026-04-11T01:17:26.892Zalways0.5https://insights.citeline.com/resizer/8miNFdJ1dCiL5nD__nGDRPHLMYI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BETANQBYSJH5HAX34IBKBVZ2PE.jpghttps://insights.citeline.com/pink-sheet/legalandip/litigation/indias-high-stakes-oral-semaglutide-battle-and-novos-snac-wall-RUW3HFOKLJG6DM3EQ76AU7NXI4/2026-04-11T01:17:12.246Zalways0.5https://insights.citeline.com/resizer/r_GJL7lh9j-2_1bxLOD3PGXusw0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QVTXIWBHFVDSRDZMLPHCNVYDK4.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/estonia-steps-into-eu-race-to-accelerate-clinical-trial-approvals-QARKPSVJ7FC5HK32R3K2M3UOHA/2026-04-11T01:16:30.944Zalways0.5https://insights.citeline.com/resizer/gdMpRM1CRDAp0clrNDWNdpCnjyE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LHZTQFCLAFB6HPLE67MEIOWV6Q.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/plausible-mechanism-case-studies-why-us-fda-guidance-matters-F2VJPUJFTBEDZMSFL4N7X6QSJI/2026-04-11T01:16:06.437Zalways0.5https://insights.citeline.com/resizer/IXng5qQOdxEia7G_gXqoAG4UPvw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Q5VXGD6R3RBFNHNOAEK2CRAEQI.jpghttps://insights.citeline.com/pink-sheet/market-access/pricing-debate/uk-us-trade-deal-zero-tariffs-on-uk-exports-and-possible-mfn-relief-for-uk-5DTZQQFH4BAGBJAXFFVGCYACTI/2026-04-11T01:15:48.806Zalways0.5https://insights.citeline.com/resizer/xhswzfRWsj78urUL6Y42AsVfxmI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EMB3MAZZNJACXI3522TIEHMV7E.jpghttps://insights.citeline.com/pink-sheet/product-reviews/complete-response-letters/us-fda-defends-review-consistency-in-second-crl-for-replimunes-rp1-N3OOF7X5SBHDXBIK7N3OQXUL7U/2026-04-11T01:14:39.906Zalways0.5https://insights.citeline.com/resizer/3IQLtI3aBpW6lhSJGx_MB9PQtY8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5CA5HS5THZCNPIPU7ADWKGYRO4.jpghttps://insights.citeline.com/companies/zibo-biopolar-changsheng-pharmaceutical-co-ltd2026-04-11T00:08:23.997Zalways0.5https://insights.citeline.com/companies/onco-innovations-au-pty-ltd2026-04-11T00:08:17.769Zalways0.5https://insights.citeline.com/companies/kallisio-inc2026-04-11T00:08:11.846Zalways0.5https://insights.citeline.com/companies/critical-innovations-llc2026-04-11T00:08:05.786Zalways0.5https://insights.citeline.com/companies/shinya-biomedicine-huzhou-co-ltd2026-04-11T00:07:59.906Zalways0.5https://insights.citeline.com/companies/icura-diagnostics-inc2026-04-11T00:07:53.631Zalways0.5https://insights.citeline.com/companies/cellular-technology-limited2026-04-11T00:07:47.782Zalways0.5https://insights.citeline.com/companies/bentec-medical2026-04-11T00:07:41.605Zalways0.5https://insights.citeline.com/companies/autus-valve-technologies-inc2026-04-11T00:07:35.749Zalways0.5https://insights.citeline.com/companies/seabelife2026-04-11T00:07:29.754Zalways0.5https://insights.citeline.com/companies/swansea-university2026-04-11T00:07:17.509Zalways0.5https://insights.citeline.com/companies/suzhou-youthen-biotechnology-co-ltd2026-04-11T00:07:11.831Zalways0.5https://insights.citeline.com/companies/ssy-group2026-04-11T00:07:05.76Zalways0.5https://insights.citeline.com/companies/zhejiang-haizhou-pharmaceutical-co-ltd2026-04-11T00:06:59.379Zalways0.5https://insights.citeline.com/companies/oryon-cell-therapies2026-04-11T00:06:53.655Zalways0.5https://insights.citeline.com/companies/solstice-oncology2026-04-11T00:06:47.435Zalways0.5https://insights.citeline.com/companies/proxima-bio2026-04-11T00:06:41.486Zalways0.5https://insights.citeline.com/companies/ccm-biosciences-inc2026-04-11T00:06:35.458Zalways0.5https://insights.citeline.com/companies/biojiva-llc2026-04-11T00:06:29.348Zalways0.5https://insights.citeline.com/companies/vivatides-therapeutics-inc2026-04-11T00:06:23.081Zalways0.5https://insights.citeline.com/companies/institut-pasteur2026-04-11T00:06:17.441Zalways0.5https://insights.citeline.com/companies/novamigra-therapeutics2026-04-11T00:06:11.101Zalways0.5https://insights.citeline.com/companies/cyclerion-therapeutics-inc2026-04-11T00:06:05.271Zalways0.5https://insights.citeline.com/companies/atreca-inc2026-04-11T00:05:58.883Zalways0.5https://insights.citeline.com/companies/rose-pharma2026-04-11T00:05:53.031Zalways0.5https://insights.citeline.com/companies/avidity-biosciences-inc2026-04-11T00:05:46.979Zalways0.5https://insights.citeline.com/companies/asha-therapeutics2026-04-11T00:05:41.14Zalways0.5https://insights.citeline.com/companies/neurometrix2026-04-11T00:05:34.986Zalways0.5https://insights.citeline.com/companies/quotient-therapeutics-inc2026-04-11T00:05:28.98Zalways0.5https://insights.citeline.com/companies/shionogi-apnimed-sleep-science-llc2026-04-11T00:05:23.013Zalways0.5https://insights.citeline.com/companies/juntendo-university-school-of-medicine2026-04-11T00:05:17.018Zalways0.5https://insights.citeline.com/companies/blacksmith-medicines2026-04-11T00:05:10.886Zalways0.5https://insights.citeline.com/companies/third-harmonic-bio-inc2026-04-11T00:05:04.882Zalways0.5https://insights.citeline.com/companies/china-resources-pharmaceutical-group-limited2026-04-11T00:04:58.997Zalways0.5https://insights.citeline.com/companies/qsam-biosciences2026-04-11T00:04:52.679Zalways0.5https://insights.citeline.com/companies/goodman-co-ltd2026-04-11T00:04:46.681Zalways0.5https://insights.citeline.com/companies/parnell-pharmaceuticals-inc2026-04-11T00:04:40.836Zalways0.5https://insights.citeline.com/companies/lipum-ab2026-04-11T00:04:34.752Zalways0.5https://insights.citeline.com/companies/rimonyx-pharmaceuticals-ltd2026-04-11T00:04:30.731Zalways0.5https://insights.citeline.com/companies/hologic-inc2026-04-11T00:04:22.479Zalways0.5https://insights.citeline.com/companies/dermtech-inc2026-04-11T00:04:16.442Zalways0.5https://insights.citeline.com/companies/zentiva-group-as2026-04-11T00:04:10.633Zalways0.5https://insights.citeline.com/companies/sandoz-group-ag2026-04-11T00:04:04.476Zalways0.5https://insights.citeline.com/companies/yale-school-of-medicine2026-04-11T00:03:58.526Zalways0.5https://insights.citeline.com/companies/karuna-therapeutics-inc2026-04-11T00:03:52.414Zalways0.5https://insights.citeline.com/companies/oncolytics-biotech-inc2026-04-11T00:03:46.409Zalways0.5https://insights.citeline.com/companies/nanostring-technologies-inc2026-04-11T00:03:34.5Zalways0.5https://insights.citeline.com/companies/stanford-university2026-04-11T00:03:25.369Zalways0.5https://insights.citeline.com/companies/allovir-inc2026-04-11T00:03:13.21Zalways0.5https://insights.citeline.com/companies/terns-pharmaceuticals-inc2026-04-11T00:03:01.393Zalways0.5https://insights.citeline.com/companies/viracta-therapeutics-inc2026-04-11T00:02:49.285Zalways0.5https://insights.citeline.com/companies/urgo-group2026-04-11T00:02:37.206Zalways0.5https://insights.citeline.com/companies/biocare-medical-llc2026-04-11T00:02:25.433Zalways0.5https://insights.citeline.com/companies/bioporto-diagnostics-as2026-04-11T00:02:13.376Zalways0.5https://insights.citeline.com/companies/kurve-technology-inc2026-04-11T00:02:01.194Zalways0.5https://insights.citeline.com/companies/inspire-medical-systems-inc2026-04-11T00:01:49.273Zalways0.5https://insights.citeline.com/companies/ose-immunotherapeutics2026-04-11T00:01:37.149Zalways0.5https://insights.citeline.com/companies/assertio-holdings-inc2026-04-11T00:01:25.18Zalways0.5https://insights.citeline.com/companies/marinus-pharmaceuticals-inc2026-04-11T00:01:13.236Zalways0.5https://insights.citeline.com/companies/exact-sciences-corp2026-04-11T00:01:01.013Zalways0.5https://insights.citeline.com/companies/viatris-inc2026-04-11T00:00:49.277Zalways0.5https://insights.citeline.com/companies/cg-invites-co-ltd2026-04-11T00:00:37.309Zalways0.5